H-1B Filings
1
DOL labor condition applications on file
Azurity Pharmaceuticals, Inc. in MA (Manufacturing) pairs H-1B sponsorship (1 LCAs) with WARN history (1 notice) and has no employer OSHA injury log here.
Azurity Pharmaceuticals, Inc. (MA): · 1 H-1B LCA · 1 WARN notice
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, Azurity Pharmaceuticals, Inc. in MA carries 1 H-1B wage filing on record and 1 WARN layoff notice on file. H-1B filing volume ranks #17,049 of 36,919 sponsors in this corpus (about the 0th percentile). Every figure is a federal filing, not an estimate; see methodology for coverage limits.
Layoff & federal record
According to U.S. Department of Labor, OSHA, and state WARN Act filings, Azurity Pharmaceuticals, Inc. carries 1 H-1B wage filing on record and 1 WARN layoff notice on file. In this corpus, H-1B filing volume ranks #17,049 of 36,919 sponsors in this corpus (about the 0th percentile), and WARN notice count sits below 3% of 290,575 employers (more notices elsewhere).
Figures above come from DOL H-1B LCAs and state WARN notices; no employer OSHA injury log is on file here.
H-1B Filings
1
DOL labor condition applications on file
WARN Workforce Impact
75 workers
1 WARN Act notice on file
| Field | Value | Source |
|---|---|---|
| Employer Name | Azurity Pharmaceuticals, Inc. | DOL OFLC / WARN |
| Industry | Manufacturing | NAICS / DOL |
| State | MA | U.S. Federal Records |
| H-1B Filings | 1 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | Not reported | DOL OFLC LCA Disclosure |
| WARN Layoff Notices | 1 notice(s), 75 workers | WARN Act notices, state workforce agency originals (archival backstop: LayoffData.com) |
| Tracks not on file | employer OSHA injury log | Empty by design, not estimated |
Azurity Pharmaceuticals, Inc.'s values above reflect the most recent DOL Labor Condition Applications, WARN Act notices on file for this employer in MA (Manufacturing).
| Job Title | Median |
|---|---|
| Manager of Brand Insights (Business Intelligence) | N/A |
Azurity Pharmaceuticals, Inc. operating in MA within the Manufacturing sector: the company has filed 1 H-1B labor condition applications. Records here combine U.S. Department of Labor disclosures and state workforce agency filings.
1 WARN Act notice affecting 75 workers has been filed against Azurity Pharmaceuticals, Inc. in MA. Multiple notices can mean consolidations or broader restructuring; weigh them next to this employer's pay and safety signals, and the employer's own disclosures, when judging an offer.
Azurity Pharmaceuticals, Inc. is one of the rarer profiles that carries both sponsorship volume (1 H-1B LCAs) and WARN history (1 notice) in the same public record for Manufacturing in MA. Weigh those two signals separately before treating either as the whole story.
Azurity Pharmaceuticals, Inc.'s nearest H-1B-filing peers in Manufacturing (home state MA). Each card links to that employer's federal-records profile.
| Notice Date | Workers |
|---|---|
| 2025-07-08 | 75 |
What to check before working with Azurity Pharmaceuticals, Inc.
Azurity Pharmaceuticals, Inc. needs a three-way read: H-1B pay (1 LCAs), safety, and WARN history (1 notice); none of those alone is the rating.
Azurity Pharmaceuticals, Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Learn more: Safety Grades Explained | H-1B Salary Negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings and state WARN Act layoff notices, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.